Published September 29, 2026 | Version v1

ARTERIAL GIPERTENZIYA BILAN KASALLANGAN BEMORLARDA YURAK ISHEMIK KASALLIGINING YUQORI XAVF OMILLARINI ERTA ANIQLASH, PROFILAKTIKA VA TERAPIYANI OPTIMALLASHTIRISH

  • 1. Kardiologiya yo'nalishi klinik ordinatori Central Asian Medical University
  • 2. Ilmiy raxbar

Description

Arterial gipertenziya yurak-qon tomir kasalliklarining eng muhim o‘zgartirilishi mumkin bo‘lgan xavf omillaridan biri bo‘lib, uzoq muddat davomida nazorat qilinmagan arterial bosim yurak ishemik kasalligi, miokard infarkti, yurak yetishmovchiligi va boshqa yurak-qon tomir asoratlari rivojlanish xavfini oshiradi. Jahon sog‘liqni saqlash tashkiloti ma’lumotlariga ko‘ra, 2024-yilda 30–79 yoshdagi taxminan 1,4 milliard kishi arterial gipertenziyaga ega bo‘lgan. Shu bilan birga, bemorlarning katta qismida arterial gipertenziya yetarli darajada nazorat qilinmaydi. Mazkur maqolada arterial gipertenziya bilan kasallangan bemorlarda yurak ishemik kasalligi rivojlanishining asosiy xavf omillarini erta aniqlash, ularni kompleks baholash, profilaktik choralarni takomillashtirish hamda antihipertenziv terapiyani individualizatsiya qilish masalalari tahlil qilindi. Tahlilda arterial bosim darajasi, yosh, semirish, dislipidemiya, qandli diabet, chekish, jismoniy faollikning yetishmasligi, noto‘g‘ri ovqatlanish, buyrak faoliyati va oilaviy anamnez kabi omillarga e’tibor qaratildi. Yurak-qon tomir xavfini faqat arterial bosim ko‘rsatkichi bilan emas, balki bemorning umumiy xavf profili asosida baholash zarurligi asoslandi.

Files

1281-1285.pdf

Files (193.0 kB)

Name Size Download all
md5:cc44ae2ef8802a4750e7261230c81488
193.0 kB Preview Download

Additional details

References

  • 1.European Society of Cardiology. 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension.
  • 2.European Society of Cardiology. 2024 ESC Guidelines for the management of chronic coronary syndromes.
  • 3.World Health Organization. Cardiovascular diseases (CVDs). 31 July 2025.
  • 4.World Health Organization. Global report on hypertension 2025: high stakes – turning evidence into action. 2025.
  • 5.World Health Organization. Guideline for the pharmacological treatment of hypertension in adults.